SC 13G: Fractyl Health, Inc.

AI Summary

SC 13G filing by Fractyl Health, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.00001 — me of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securiti
• $0.0001 — f Securities: Common Stock, par value $0.0001 per share. (e) CUSIP Number: 35168W10

Filing Documents

• d775588dsc13g.htm (SC 13G) — 83KB
• d775588dex991.htm (EX-99.1) — 10KB
• 0001193125-24-038760.txt ( ) — 95KB

From the Filing

SC 13G 1 d775588dsc13g.htm SC 13G SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* Fractyl Health, Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 35168W103 (CUSIP Number) Christopher McCain General Catalyst Partners 20 University Road, 4th Floor, Cambridge, MA 02138 (617) 234-7000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 6, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 35168W103 13G 1. Names of Reporting Persons General Catalyst GP V, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization USA Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,884,186 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,884,186 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,884,186 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 10.02% 12. Type of Reporting Person (See Instructions) OO CUSIP No. 35168W103 13G 1. Names of Reporting Persons General Catalyst Partners V, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization USA Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,884,186 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,884,186 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,884,186 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 10.02% 12. Type of Reporting Person (See Instructions) PN CUSIP No. 35168W103 13G 1. Names of Reporting Persons General Catalyst Group V, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization USA Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,884,186 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,884,186 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,884,186 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 10.02% 12. Type of Reporting Person (See Instructions) PN CUSIP No. 35168W103 13G 1. Names of Reporting Persons GC Entrepreneurs Fund V, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization USA Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 4,884,186 7. Sole Dispositive Power 0 8. Shared Dispositive Power 4,884,186 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,884,186 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 10.02% 12. Type of Reporting Person (See Instructions) PN CUSIP No. 35168W103 13G Item1. (a) Name of Issuer: Fractyl Health, Inc. (b) Address of Issuers Principal Executive Offices: 17 Hartwell Avenue, Lexington, Massachusetts 02421 Item2. (a) Name of Person Filing: This joint statement on Schedule 13G is being filed by General Catalyst GP V, LLC, a Delaware limited liability company (GCGPV), General Catalyst Partners V, L.P., a Delaware limited partnership (GCGV GPLP), General Catalyst Group V, L.P., a Delaware limited partnership (GCGV) and GC E

View Full Filing

View this SC 13G filing on SEC EDGAR